BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8733902)

  • 1. Temporary improvement of neurological symptoms with gammaglobulin therapy in a boy with adrenoleukodystrophy.
    Oka A; Saito M; Kubota M; Sakakihara Y; Yanagisawa M
    Brain Dev; 1996; 18(2):119-21. PubMed ID: 8733902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of clinical and MRI findings in a boy with adrenoleukodystrophy by dietary erucic acid therapy.
    Maeda K; Suzuki Y; Yajima S; Asano J; Yamaguchi S; Matsumoto N; Borel J; Moser HW; Orii T
    Brain Dev; 1992 Nov; 14(6):409-12. PubMed ID: 1492654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 4. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
    Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
    N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy in a Chinese boy.
    Wong V
    Brain Dev; 1992 Jul; 14(4):276-7. PubMed ID: 1279999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope.
    Moser HW
    Ann Neurol; 1993 Aug; 34(2):121-2. PubMed ID: 8338333
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
    Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
    Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenoleukodystrophy: a link between adrenal insufficiency and school performance.
    Bakos JT; Goen P; Ogden A; Brown FR; Karaviti LP
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2869-72. PubMed ID: 7559867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 12. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 13. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 14. Localized proton magnetic resonance spectroscopy in patients with adult adrenoleukodystrophy. Increase of choline compounds in normal appearing white matter.
    Tourbah A; Stievenart JL; Iba-Zizen MT; Lubetzki C; Baumann N; Eymard B; Moser HW; Lyon-Caen O; Cabanis EA
    Arch Neurol; 1997 May; 54(5):586-92. PubMed ID: 9152115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
    Tanaka M; Koike R; Kuwabara T
    Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
    [No Abstract]   [Full Text] [Related]  

  • 18. Lorenzo's oil and lymphocytopenia.
    Unkrig CJ; Schröder R; Scharf RE
    N Engl J Med; 1994 Feb; 330(8):577. PubMed ID: 8204158
    [No Abstract]   [Full Text] [Related]  

  • 19. Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil).
    Rasmussen M; Moser AB; Borel J; Khangoora S; Moser HW
    Neurochem Res; 1994 Aug; 19(8):1073-82. PubMed ID: 7800117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.